Cargando…

Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events

BACKGROUND: Breast cancer outcome, including response to therapy, risk of metastasis and survival, is difficult to predict using currently available methods, highlighting the urgent need for more informative biomarkers. Androgen receptor (AR) has been implicated in breast carcinogenesis however its...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Kate M, Edwards, Stacey L, Nair, Shalima S, French, Juliet D, Bailey, Peter J, Salkield, Kathryn, Stein, Sandra, Wagner, Sarah, Francis, Glenn D, Clark, Susan J, Brown, Melissa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349557/
https://www.ncbi.nlm.nih.gov/pubmed/22471922
http://dx.doi.org/10.1186/1471-2407-12-132
_version_ 1782232523163566080
author Peters, Kate M
Edwards, Stacey L
Nair, Shalima S
French, Juliet D
Bailey, Peter J
Salkield, Kathryn
Stein, Sandra
Wagner, Sarah
Francis, Glenn D
Clark, Susan J
Brown, Melissa A
author_facet Peters, Kate M
Edwards, Stacey L
Nair, Shalima S
French, Juliet D
Bailey, Peter J
Salkield, Kathryn
Stein, Sandra
Wagner, Sarah
Francis, Glenn D
Clark, Susan J
Brown, Melissa A
author_sort Peters, Kate M
collection PubMed
description BACKGROUND: Breast cancer outcome, including response to therapy, risk of metastasis and survival, is difficult to predict using currently available methods, highlighting the urgent need for more informative biomarkers. Androgen receptor (AR) has been implicated in breast carcinogenesis however its potential to be an informative biomarker has yet to be fully explored. In this study, AR protein levels were determined in a cohort of 73 Grade III invasive breast ductal adenocarcinomas. METHODS: The levels of Androgen receptor protein in a cohort of breast tumour samples was determined by immunohistochemistry and the results were compared with clinical characteristics, including survival. The role of defects in the regulation of Androgen receptor gene expression were examined by mutation and methylation screening of the 5' end of the gene, reporter assays of the 5' and 3' end of the AR gene, and searching for miRNAs that may regulate AR gene expression. RESULTS: AR was expressed in 56% of tumours and expression was significantly inversely associated with 10-year survival (P = 0.004). An investigation into the mechanisms responsible for the loss of AR expression revealed that hypermethylation of the AR promoter is associated with loss of AR expression in breast cancer cells but not in primary breast tumours. In AR negative breast tumours, mutation screening identified the same mutation (T105A) in the 5'UTR of two AR negative breast cancer patients but not reported in the normal human population. Reporter assay analysis of this mutation however found no evidence for a negative impact on AR 5'UTR activity. The role of miR-124 in regulating AR expression was also investigated, however no evidence for this was found. CONCLUSION: This study highlights the potential for AR expression to be an informative biomarker for breast cancer survival and sets the scene for a more comprehensive investigation of the molecular basis of this phenomenon.
format Online
Article
Text
id pubmed-3349557
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33495572012-05-11 Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events Peters, Kate M Edwards, Stacey L Nair, Shalima S French, Juliet D Bailey, Peter J Salkield, Kathryn Stein, Sandra Wagner, Sarah Francis, Glenn D Clark, Susan J Brown, Melissa A BMC Cancer Research Article BACKGROUND: Breast cancer outcome, including response to therapy, risk of metastasis and survival, is difficult to predict using currently available methods, highlighting the urgent need for more informative biomarkers. Androgen receptor (AR) has been implicated in breast carcinogenesis however its potential to be an informative biomarker has yet to be fully explored. In this study, AR protein levels were determined in a cohort of 73 Grade III invasive breast ductal adenocarcinomas. METHODS: The levels of Androgen receptor protein in a cohort of breast tumour samples was determined by immunohistochemistry and the results were compared with clinical characteristics, including survival. The role of defects in the regulation of Androgen receptor gene expression were examined by mutation and methylation screening of the 5' end of the gene, reporter assays of the 5' and 3' end of the AR gene, and searching for miRNAs that may regulate AR gene expression. RESULTS: AR was expressed in 56% of tumours and expression was significantly inversely associated with 10-year survival (P = 0.004). An investigation into the mechanisms responsible for the loss of AR expression revealed that hypermethylation of the AR promoter is associated with loss of AR expression in breast cancer cells but not in primary breast tumours. In AR negative breast tumours, mutation screening identified the same mutation (T105A) in the 5'UTR of two AR negative breast cancer patients but not reported in the normal human population. Reporter assay analysis of this mutation however found no evidence for a negative impact on AR 5'UTR activity. The role of miR-124 in regulating AR expression was also investigated, however no evidence for this was found. CONCLUSION: This study highlights the potential for AR expression to be an informative biomarker for breast cancer survival and sets the scene for a more comprehensive investigation of the molecular basis of this phenomenon. BioMed Central 2012-04-02 /pmc/articles/PMC3349557/ /pubmed/22471922 http://dx.doi.org/10.1186/1471-2407-12-132 Text en Copyright ©2012 Peters et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Peters, Kate M
Edwards, Stacey L
Nair, Shalima S
French, Juliet D
Bailey, Peter J
Salkield, Kathryn
Stein, Sandra
Wagner, Sarah
Francis, Glenn D
Clark, Susan J
Brown, Melissa A
Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
title Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
title_full Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
title_fullStr Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
title_full_unstemmed Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
title_short Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
title_sort androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349557/
https://www.ncbi.nlm.nih.gov/pubmed/22471922
http://dx.doi.org/10.1186/1471-2407-12-132
work_keys_str_mv AT peterskatem androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT edwardsstaceyl androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT nairshalimas androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT frenchjulietd androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT baileypeterj androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT salkieldkathryn androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT steinsandra androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT wagnersarah androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT francisglennd androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT clarksusanj androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents
AT brownmelissaa androgenreceptorexpressionpredictsbreastcancersurvivaltheroleofgeneticandepigeneticevents